Radiopharm Theranostics Limited (RADX) Financials
RADX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 41.6 million | 26.1 million |
| Dec. 31, 2025 | 60.8 million | 27.5 million |
| Dec. 31, 2024 | 57.4 million | 25.1 million |
| Sept. 30, 2024 | ? | ? |
RADX Free Cash Flow and Stock based compensation
No data available :(
RADX Net Income
No data available :(
RADX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2.9 million | - | - |
| Dec. 31, 2025 | 23.0 million | - | - |
| Dec. 31, 2024 | 22.6 million | - | - |
| Sept. 30, 2024 | - | - | - |
RADX Shares Outstanding
RADX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 22.2 million | - | 4.4 million | - |
| Dec. 31, 2025 | 2 | 13.1 million | 6.5 million | - |
| Dec. 31, 2024 | - | - | - | - |
| Sept. 30, 2024 | - | - | - | - |
RADX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 968952 | 856585 |
| Dec. 31, 2025 | 908465 | 1.7 million |
| Dec. 31, 2024 | - | - |
| Sept. 30, 2024 | - | - |
RADX
Price: $1.01
52 week price:
Earnings Per Share: -3.63 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.8 million